title: Pfizer's open data policy should include trials of off-label uses, say critics.
authors: BMJ.
authors: Zosia
authors: Z
authors: Kmietowicz
mesh_terms: D002986:Clinical Trials as Topic; D004345:Drug Industry; D006801:Humans; D033181:Information Dissemination; D056687:Off-Label Use; D018579:Patient Selection